RSSDI Repository, Complications of Diabetes Demonstration
RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

Advanced Search
  • Home/
  • Article /
  • Use of prohibited medication, a potentially overlooked confounder in clinical trials: omarigliptin (once-weekly DPP-4 inhibitor) monotherapy trial in 18-to 45 …

Use of prohibited medication, a potentially overlooked confounder in clinical trials: omarigliptin (once-weekly DPP-4 inhibitor) monotherapy trial in 18-to 45 …

Add to Collection
RCTs I Gantz, L Sokolova, L Jain, C Iredale, EA O'Neill… - Clinical Therapeutics, 2017 - Elsevier

Chapter : Section9
Journal Year : 2017
Cited by : 7

… adult patients with type 2 diabetes mellitus (T2DM). Unexpected … meters and test strips for self-monitoring of blood glucose (SMBG). … to collect information on any events of hypoglycemia. …..... Read More

Keywords : ['clinical trial omarigliptin onceweekly inhibitor monotherapy trial', 'potentially overlook confounder', 'prohibit medication', 'use']
PubMed Link : https://www.sciencedirect.com/science/article/pii/S0149291817308986
Google Scholar Link : https://scholar.google.com/scholar?cites=12693082432964882716&as_sdt=2005&sciodt=0,5&hl=en&num=20